Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense pro-drugs: 5'-ester oligodeoxynucleotides

N N Polushin1, J S Cohen

  • 1Cancer Pharmacology Section, Georgetown University Medical Center, Washington DC 20007.

Nucleic Acids Research
|December 11, 1994
PubMed
Summary

Synthesizing lipophilic oligonucleotides for enhanced cellular uptake was challenging. A novel method using specific protecting groups and ethanolamine achieved successful synthesis of 5'-palmitoyl oligodeoxynucleotides.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incremental risk of fragility fractures in aging men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms.

Clinical genetics·2017
Same author

Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.

Clinical genetics·2017
Same author

Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features.

Clinical genetics·2016
Same author

Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.

Clinical genetics·2014
Same author

The role of trial tracking on rats' successive delayed matching-to-sample modality performance.

Behavioural processes·2014

Area of Science:

  • Oligonucleotide synthesis
  • Medicinal chemistry
  • Drug delivery

Background:

  • Lipophilic oligonucleotides offer potential as antisense pro-drugs due to improved cellular uptake.
  • The ester bond linkage for lipophilic modification is susceptible to degradation during standard oligonucleotide deprotection methods.

Purpose of the Study:

  • To develop a robust synthesis strategy for 5 eal-ester oligonucleotides resistant to deprotection conditions.
  • To enable the efficient production of lipophilic oligodeoxynucleotides for potential therapeutic applications.

Main Methods:

  • Utilized base-labile tert-butylphenoxyacetyl amino protecting groups (t-BPA).
  • Employed an oxalyl-controlled pore glass (CPG) anchor group.
  • Developed a novel deprotection protocol using ethanolamine (EA) instead of aqueous ammonia.

Main Results:

  • Successfully synthesized 5 eal-palmitoyl oligodeoxynucleotides with good yields.
  • Demonstrated the stability of the 5 eal-ester linkage under the new deprotection conditions.
  • Overcame the lability issues associated with traditional oligonucleotide synthesis.

Conclusions:

  • The developed method provides a reliable route for synthesizing 5 eal-ester modified oligonucleotides.
  • This advancement facilitates the creation of novel antisense pro-drugs with enhanced delivery capabilities.
  • The combination of t-BPA protecting groups, oxalyl-CPG anchor, and EA deprotection is effective for lipophilic oligonucleotide synthesis.

Related Experiment Videos